MetLife Investment Management’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.01M | Hold |
|
|||||
|
2025
Q2 | $794K | Hold |
|
|||||
|
2025
Q1 | $708K | Sell |
|
|||||
|
2024
Q4 | $1M | Buy |
|
|||||
|
2024
Q3 | $1.27M | Hold |
|
|||||
|
2024
Q2 | $1.38M | Buy |
|
|||||
|
2024
Q1 | $1.33M | Buy |
|
|||||
|
2023
Q4 | $955K | Hold |
|
|||||
|
2023
Q3 | $662K | Hold |
|
|||||
|
2023
Q2 | $817K | Buy |
|
|||||
|
2023
Q1 | $854K | Sell |
|
|||||
|
2022
Q4 | $1.1M | Sell |
|
|||||
|
2022
Q3 | $709K | Hold |
|
|||||
|
2022
Q2 | $680K | Hold |
|
|||||
|
2022
Q1 | $859K | Buy |
|
|||||
|
2021
Q4 | $620K | Hold |
|
|||||
|
2021
Q3 | $867K | Buy |
|
|||||
|
2021
Q2 | $485K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $55K | Sell |
|
|||||
|
2017
Q4 | $187K | Buy |
|